The EU project REVIVE-CAP, in which the NUM Specialist Network for Infections (SNID) is participating as a partner, has been approved for funding by the European Commission. It received an outstanding score of 15 out of 15 points from among more than 100 applications submitted. This marks the first time the specialist network has been involved in an international study.
The aim of REVIVE-CAP is to gain a better understanding of the previously underestimated risk of serious cardiovascular events following pneumonia and to enable early detection. The project is led by Prof. Evelina Tacconelli from the Università di Verona in Italy.
The study has already been presented to the SNID Steering Committee, where it was well received. As part of the project, SNID will participate in a prospective cohort study. A key factor in the selection of SNID was, in particular, the demonstrable success in recruiting participants for the respiratory infections module of the SNID baseline cohort. Specifically, the plan is to carry out standardised clinical data collection on patients, as well as structured follow-up, in order to gain a better long-term understanding of the course of the disease and the quality of life of those affected.
The Specialty Network Infectious Diseases within the NUM Study Network (NUM SN) supports clinical and clinical-epidemiological studies in the field of infectious diseases.
Gaining a better understanding of the risk of serious cardiovascular events following pneumonia: the Infectious Diseases Expert Network takes part in an international study for the first time
